Armistice Capital as of Dec. 31, 2018
Portfolio Holdings for Armistice Capital
Armistice Capital holds 69 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 28.4 | $375M | 1.5M | 249.92 | |
| Clovis Oncology | 6.8 | $90M | 5.0M | 17.96 | |
| Cerecor | 4.4 | $59M | 18M | 3.23 | |
| Energizer Holdings (ENR) | 3.6 | $48M | 1.1M | 45.15 | |
| J.M. Smucker Company (SJM) | 3.1 | $41M | 440k | 93.49 | |
| Playa Hotels & Resorts Nv (PLYA) | 3.1 | $41M | 5.7M | 7.19 | |
| Edgewell Pers Care (EPC) | 2.9 | $38M | 1.0M | 37.35 | |
| Mallinckrodt Pub | 2.8 | $36M | 2.3M | 15.80 | |
| Enanta Pharmaceuticals (ENTA) | 2.7 | $35M | 500k | 70.83 | |
| Tempur-Pedic International (SGI) | 2.6 | $34M | 824k | 41.40 | |
| Del Friscos Restaurant | 2.5 | $32M | 4.5M | 7.15 | |
| Stericycle (SRCL) | 2.4 | $32M | 858k | 36.69 | |
| AMAG Pharmaceuticals | 2.2 | $29M | 1.9M | 15.19 | |
| Antares Pharma | 2.1 | $28M | 10M | 2.72 | |
| Voyager Therapeutics (VYGR) | 2.0 | $27M | 2.8M | 9.40 | |
| Regeneron Pharmaceuticals (REGN) | 2.0 | $26M | 70k | 373.50 | |
| Progenics Pharmaceuticals | 1.8 | $24M | 5.7M | 4.20 | |
| CVS Caremark Corporation (CVS) | 1.8 | $24M | 358k | 65.52 | |
| Welbilt | 1.5 | $20M | 1.8M | 11.11 | |
| Frontdoor (FTDR) | 1.2 | $16M | 600k | 26.61 | |
| TJX Companies (TJX) | 1.0 | $13M | 300k | 44.74 | |
| AutoZone (AZO) | 1.0 | $13M | 16k | 838.31 | |
| Spectrum Pharmaceuticals | 1.0 | $13M | 1.5M | 8.75 | |
| Strongbridge Bioph shs usd | 1.0 | $13M | 2.9M | 4.48 | |
| Alexion Pharmaceuticals | 0.9 | $12M | 124k | 97.36 | |
| Assertio Therapeutics | 0.9 | $12M | 3.3M | 3.61 | |
| Foot Locker | 0.8 | $11M | 212k | 53.20 | |
| Ptc Therapeutics I (PTCT) | 0.8 | $10M | 300k | 34.32 | |
| Paratek Pharmaceuticals | 0.8 | $10M | 2.0M | 5.13 | |
| Cellectis S A (CLLS) | 0.7 | $9.8M | 589k | 16.65 | |
| Solid Biosciences | 0.7 | $8.9M | 332k | 26.80 | |
| Marker Therapeutics Ord | 0.6 | $8.3M | 1.5M | 5.55 | |
| Eyegate Pharmaceuticals | 0.6 | $8.1M | 17M | 0.47 | |
| Alphatec Holdings (ATEC) | 0.6 | $7.6M | 3.3M | 2.29 | |
| Cedar Fair | 0.5 | $7.1M | 150k | 47.30 | |
| Ollies Bargain Outlt Hldgs I (OLLI) | 0.5 | $7.2M | 108k | 66.51 | |
| Achillion Pharmaceuticals | 0.5 | $6.8M | 4.3M | 1.59 | |
| Target Corporation (TGT) | 0.5 | $6.6M | 100k | 66.09 | |
| Advance Auto Parts (AAP) | 0.5 | $6.6M | 42k | 157.45 | |
| Valeritas Hldgs | 0.5 | $6.6M | 20M | 0.33 | |
| Incyte Corporation (INCY) | 0.5 | $6.4M | 100k | 63.59 | |
| Five Below (FIVE) | 0.5 | $6.1M | 60k | 102.32 | |
| Zafgen | 0.5 | $6.2M | 1.3M | 4.95 | |
| Adamas Pharmaceuticals | 0.4 | $5.6M | 658k | 8.54 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.4 | $5.7M | 22M | 0.26 | |
| Vical | 0.4 | $5.1M | 4.4M | 1.18 | |
| Alimera Sciences | 0.4 | $5.0M | 6.9M | 0.72 | |
| Crispr Therapeutics (CRSP) | 0.4 | $4.9M | 172k | 28.57 | |
| Flexion Therapeutics | 0.3 | $4.5M | 400k | 11.32 | |
| Ovid Therapeutics (OVID) | 0.3 | $3.9M | 1.6M | 2.42 | |
| Naked Brand Group Limited ord | 0.2 | $3.3M | 3.9M | 0.84 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.2 | $2.6M | 1.4M | 1.92 | |
| Assembly Biosciences | 0.2 | $2.3M | 100k | 22.62 | |
| Sierra Oncology | 0.2 | $2.1M | 1.6M | 1.32 | |
| Medigus Ltd *w exp 07/23/202 | 0.1 | $1.7M | 1.3M | 1.36 | |
| Dynatronics | 0.1 | $1.5M | 561k | 2.73 | |
| Oramed Pharm (ORMP) | 0.1 | $1.6M | 543k | 3.00 | |
| Castle Brands | 0.1 | $886k | 1.0M | 0.85 | |
| Apricus Biosciences | 0.1 | $874k | 4.6M | 0.19 | |
| Citius Pharmaceuticals | 0.1 | $768k | 738k | 1.04 | |
| Under Armour (UAA) | 0.0 | $530k | 30k | 17.67 | |
| Achieve Life Science | 0.0 | $542k | 448k | 1.21 | |
| Pulmatrix | 0.0 | $414k | 1.7M | 0.24 | |
| Synthetic Biologics | 0.0 | $312k | 557k | 0.56 | |
| Neuralstem | 0.0 | $183k | 590k | 0.31 | |
| Tenax Therapeutics | 0.0 | $102k | 85k | 1.21 | |
| Aytu Bioscience | 0.0 | $79k | 100k | 0.79 | |
| Ritter Pharmaceuticals | 0.0 | $30k | 51k | 0.59 | |
| Onconova Therapeutics | 0.0 | $62k | 29k | 2.12 |